Cigna (NYSE:CI) posted its quarterly earnings results on Thursday. The health services provider reported $5.81 earnings per share for the quarter, beating the Zacks’ consensus estimate of $5.15 by $0.66, MarketWatch Earnings reports. The company had revenue of $39.27 billion for the quarter, compared to the consensus estimate of $37.93 billion. Cigna had a return on equity of 15.89% and a net margin of 3.41%. The firm’s quarterly revenue was up 14.2% on a year-over-year basis. During the same quarter in the prior year, the business posted $4.30 EPS. Cigna updated its FY 2020
Pre-Market guidance to 18.00-18.60 EPS and its FY20 guidance to $18.00-18.60 EPS.

Shares of NYSE CI traded down $5.78 during mid-day trading on Friday, hitting $172.69. The company had a trading volume of 2,452,731 shares, compared to its average volume of 1,887,986. The company has a market capitalization of $63.72 billion, a PE ratio of 12.29, a price-to-earnings-growth ratio of 0.87 and a beta of 0.70. The firm has a 50-day simple moving average of $184.19 and a two-hundred day simple moving average of $189.90. The company has a current ratio of 0.74, a quick ratio of 0.67 and a debt-to-equity ratio of 0.67. Cigna has a one year low of $118.50 and a one year high of $224.64.

CI has been the topic of several research analyst reports. Barclays dropped their price objective on Cigna from $232.00 to $229.00 and set an “overweight” rating on the stock in a research note on Monday, May 4th. BMO Capital Markets raised their price objective on Cigna from $215.00 to $242.00 and gave the stock an “outperform” rating in a research note on Friday, June 5th. SunTrust Banks dropped their price objective on Cigna from $280.00 to $240.00 and set a “buy” rating on the stock in a research note on Monday, April 13th. Sanford C. Bernstein downgraded Cigna from an “outperform” rating to a “market perform” rating and set a $223.00 price objective on the stock. in a research note on Monday, May 4th. Finally, UBS Group lowered their target price on Cigna from $252.00 to $246.00 and set a “buy” rating for the company in a report on Friday, June 5th. Two equities research analysts have rated the stock with a sell rating, three have issued a hold rating, sixteen have assigned a buy rating and one has issued a strong buy rating to the stock. Cigna presently has an average rating of “Buy” and an average target price of $244.00.

In related news, EVP John M. Murabito sold 4,338 shares of the business’s stock in a transaction on Monday, June 8th. The shares were sold at an average price of $215.00, for a total value of $932,670.00. Following the sale, the executive vice president now owns 56,762 shares of the company’s stock, valued at $12,203,830. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director John Partridge sold 2,700 shares of the business’s stock in a transaction on Monday, July 13th. The stock was sold at an average price of $180.04, for a total transaction of $486,108.00. Following the completion of the sale, the director now directly owns 27,216 shares in the company, valued at approximately $4,899,968.64. The disclosure for this sale can be found here. Insiders have sold 231,802 shares of company stock valued at $48,470,825 in the last quarter. 0.90% of the stock is currently owned by corporate insiders.

Cigna Company Profile

Cigna Corporation, a health service organization, provides insurance and related products and services in the United States and internationally. It operates through Integrated Medical, Health Services, International Markets, and Group Disability and Other segments. The Integrated Medical segment offers medical, pharmacy, dental, behavioral health and vision, health advocacy programs, and other products and services to insured and self-insured clients; Medicare Advantage, Medicare Supplement, and Medicare Part D plans to Medicare-eligible beneficiaries, as well as Medicaid plans; and health insurance coverage to individual customers on and off the public exchanges.

Featured Story: What is meant by buying and selling pressure?

Earnings History for Cigna (NYSE:CI)

Receive News & Ratings for Cigna Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna and related companies with MarketBeat.com's FREE daily email newsletter.